| NAME OF THE PROJECT | : Losartan potassium |
| PRODUCT NAME | : Losartan Potassium-2-Butyl-4-chloro-5-formylimidazole(BCFI) |
| CBNumber | :CB4185349 |
| MOLECULAR FORMULA | : C8H11ClN2O |
| MOLECULAR WEIGHT | : 186.64 |
| CAS NO | : 83857-96-9 |
| CHEMICAL NAME | :2-butyl-4-chloro-1H-imidazole-5-carbaldehyde |
| CAT NO | : LP - 4030-01-001 |
| CAS NO | : 124750-99-8 |
| Mol.F | : C22H22ClKN6O |
| Mol.Wt. | : 461 |
| CAT NO | : LP - 4030-03-007 |
| CAS NO | : 79047-41-9 |
| Mol.F | : C8H13ClN2O |
| Mol.Wt. | : 188.65 |
| CAT NO | : LP - 4030-03-008 |
| CAS NO | : 160514-13-6 |
| Mol.F | : C14H12N4O |
| Mol.Wt. | : 252.27 |
| CAT NO | : LP - 4030-03-009 |
| CAS NO | : 114799-13-2 (Free base),860644-28-6(Potassium salt) |
| Mol.F | : C22H23ClN6O |
| Mol.Wt. | : 422.91 |
| CAT NO | : LP - 4030-03-004 |
| CAS NO | : 83857-96-9 |
| Mol.F | : C8H11ClN2O |
| Mol.Wt. | : 186.64 |
| CAT NO | : LP - 4030-03-005 |
| CAS NO | : 120568-11-8 |
| Mol.F | : C15H14N4 |
| Mol.Wt. | : 250.3 |
| CAT NO | : LP - 4030-03-010 |
| CAS NO | : 76-84-6 |
| Mol.F | : C19H16O |
| Mol.Wt. | : 260.33 |
| CAT NO | : LP - 4030-03-004 |
| CAS NO | : 83857-96-9 |
| Mol.F | : C8H11ClN2O |
| Mol.Wt. | : 186.64 |
| CAT NO | : LP - 4030-03-002 |
| CAS NO | : 124750-67-0 |
| Mol.F | : C22H20ClN3O |
| Mol.Wt. | : 377.86 |
| CAT NO | : LP - 4030-03-003 |
| CAS NO | : 114772-55-3 |
| Mol.F | : C22H22ClN3O |
| Mol.Wt. | : 379.88 |
| CAT NO | : LP - 4030-03-006 |
| CAS NO | : 151052-40-3 |
| Mol.F | : C14H10N4O |
| Mol.Wt. | : 250.25 |
| CAT NO | : LP-4030-03-011 |
| CAS NO | : 114772-54-2 |
| Mol.F | : C14H10BrN |
| Mol.Wt. | : 272.14 |
| CBNumber | :CB4185349 |
| CAS NO | : 83857-96-9 |
| Mol.F | : C8H11ClN2O |
| Mol.Wt. | :186.64 |
CATEGORY : Losartan Potassium
TOTAL PRODUCTS : 12
FILTER BY : API
Lavybens pharma's competitive advanced manufacturing facilities, R & D capabilities, extensive domestic network in Indian Pharma market and International.
Copyrights © Lavybens Pharma All rights Reserved
